Cite
HARVARD Citation
Field, K. et al. (2017). The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET). Cancer. 123 (18), pp. 3576-3582. [Online].